2nd Biosimilars Congregation 2013

Organization: Virtue Insight Ltd

Venue: Marriott London Grosvenor Square

Location: London, United Kingdom

Event Date/Time: Feb 19, 2013 / 9:30 am - (GMT) End Date/Time: Feb 20, 2013 / 5:00 pm - (GMT)
Report as Spam

Description

 Super Early Discount (Till 19th December 2012):- Conference Delegate Pass (£ 500 + VAT per delegate)
Early Discount (20th December 2012 – 19th January 2013):- Conference Delegate Pass (£ 700 + VAT per delegate)
Standard Registration (After 20th January 2013):- Conference Delegate Pass (£ 900 + VAT per delegate) –
You can simply email or call and book your conference delegate seats on TEL: + 44 20 3302 4659. Email – delegate.uk@virtueinsight.com
KEY SPEAKERS:-
Paul Tredwell, Head of Biopharmaceuticals, Sandoz
Anne Cook, Biologicals Quality Assessor, MHRA
Cecil Nick, Vice President, Biotechnology, Parexel
Alex Kudrin, Medical Assessor in Licensing of Biological Products, MHRA (Former Medical Director, Takeda Pharmaceuticals)
Malcolm I Mitchell, Senior Medical Fellow, Clinical Pharmacology, Eli Lilly
Paul Greenland, Biosimilars and Proprietary Marketing Director – EMEA, Hospira
Mateja Urlep, Founder & CEO, TikhePharma
Bruno Flamion, Member, NDA Regulatory Advisory Board
Steinar Madsen, Medical Director, Norweigen Medicines Agency
Duncan Emerton, Director and Biosimilars Practice Lead, Datamonitor
Christopher Holloway, Group Director of Regulatory Affairs, European Regulatory Solutions
Richard Dennett, Director, Voisin Consulting Life Sciences (France)
Kristie C. Kuhl, Senior Vice President, Makovsky (USA)
Lincoln Tsang, Partner, Arnold & Porter

Venue

10-13 Duke Street
London
United Kingdom
MORE INFO ON THIS VENUE

Organizations

Virtue Insight Ltd